ENTRY       D07729                      Drug
NAME        Clopidogrel (USP/INN);
            Clopidogrel (TN);
            Plavix (TN)
FORMULA     C16H16ClNO2S
EXACT_MASS  321.059
MOL_WEIGHT  321.8217
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
               DG01808  Thienopyridine
             DG01809  P2Y12 receptor antagonist
              DG01808  Thienopyridine
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02919  CYP2B6 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01641  CYP2C8 inhibitor
REMARK      ATC code: B01AC04
            Chemical structure group: DG00155
            Product (DG00155): D00769<JP/US>
            Product (mixture): D10513<JP>
EFFICACY    Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist
COMMENT     Thienopyridine derivative
            CYP2C19 poor metabolizer status is associated with diminished response to Clopidogrel.
TARGET      P2RY12 [HSA:64805] [KO:K04298]
  PATHWAY   hsa04611(64805)  Platelet activation
METABOLISM  Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2B6 [HSA:1555]
INTERACTION CYP inhibition: CYP2C8 [HSA:1558]
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC04 Clopidogrel
                  D07729  Clopidogrel (USP/INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
                  D07729  Clopidogrel
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
                 D07729  Clopidogrel
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
                D07729  Clopidogrel
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
                D07729  Clopidogrel
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
                D07729  Clopidogrel
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
                 D07729  Clopidogrel
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
                D07729  Clopidogrel
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Purine / pyrimidine
                P2RY12
                 D07729  Clopidogrel (USP/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07729
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07729
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01808  Thienopyridine
                 DG00155  Clopidogrel
              DG01809  P2Y12 receptor antagonist
               DG01808  Thienopyridine
                DG00155  Clopidogrel
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00155  Clopidogrel
              DG02919  CYP2B6 substrate
               DG00155  Clopidogrel
              DG01639  CYP2C19 substrate
               DG00155  Clopidogrel
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00155  Clopidogrel
             Metabolizing enzyme inhibitor
              DG01641  CYP2C8 inhibitor
               DG00155  Clopidogrel
DBLINKS     CAS: 113665-84-2
            PubChem: 51092025
            PDB-CCD: CGE
            LigandBox: D07729
            NIKKAJI: J691.232J
ATOM        21
            1   N1y N    24.2900  -17.5700
            2   C1c C    23.1000  -18.2700
            3   C1x C    25.4800  -18.2700
            4   C1x C    24.2900  -16.1700
            5   C8y C    21.9100  -17.5700
            6   C7a C    23.1000  -19.6700
            7   C8y C    26.7400  -17.5700
            8   C1x C    25.4800  -15.4700
            9   C8y C    21.9100  -16.1700
            10  C8x C    20.6500  -18.2700
            11  O7a O    21.9100  -20.3700
            12  O6a O    24.2900  -20.3700
            13  C8y C    26.7400  -16.1700
            14  C8x C    28.0700  -17.9900
            15  C8x C    20.6500  -15.4700
            16  X   Cl   23.1000  -15.4700
            17  C8x C    19.4600  -17.5700
            18  C1a C    20.6500  -19.6700
            19  S2x S    28.0700  -15.7500
            20  C8x C    28.9100  -16.8700
            21  C8x C    19.4600  -16.1700
BOND        23
            1     2   5 1
            2     2   6 1 #Down
            3     3   7 1
            4     4   8 1
            5     5   9 1
            6     5  10 2
            7     6  11 1
            8     6  12 2
            9     7  13 2
            10    7  14 1
            11    9  15 2
            12    9  16 1
            13   10  17 1
            14   11  18 1
            15   13  19 1
            16   14  20 2
            17   15  21 1
            18    8  13 1
            19   17  21 2
            20   19  20 1
            21    1   2 1
            22    1   3 1
            23    1   4 1
///
